scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1053299129 |
P356 | DOI | 10.1186/1756-9966-28-115 |
P932 | PMC publication ID | 3225858 |
P698 | PubMed publication ID | 19682377 |
P5875 | ResearchGate publication ID | 26743586 |
P2093 | author name string | Lei Cai | |
Zhengtang Chen | |||
Yunsong Zhang | |||
Wenlei Zhuo | |||
Zhaolan Xiang | |||
P2860 | cites work | Bias in meta-analysis detected by a simple, graphical test | Q24685585 |
TP53 polymorphisms and lung cancer risk: a systematic review and meta-analysis | Q27824797 | ||
Do MDM2 SNP309 and TP53 R72P interact in breast cancer susceptibility? A large pooled series from the breast cancer association consortium | Q27851413 | ||
Cytochrome P-450 1A1 gene polymorphisms and risk of breast cancer: a HuGE review | Q28248473 | ||
Cancer statistics, 2007 | Q29547293 | ||
Importance of TP53 codon 72 and intron 3 duplication 16bp polymorphisms in prediction of susceptibility on breast cancer | Q33317092 | ||
Association of the germline TP53 R337H mutation with breast cancer in southern Brazil | Q33388533 | ||
Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis | Q33883532 | ||
Human papillomavirus as a risk factor for oral squamous cell carcinoma: a meta-analysis, 1982-1997. | Q34279292 | ||
Oral contraceptive use as a risk factor for premenopausal breast cancer: a meta-analysis | Q34573557 | ||
Polymorphisms of H-ras-1 and p53 in breast cancer and lung cancer: a meta-analysis | Q34638831 | ||
p53 codon 72 polymorphism and cervical neoplasia: a meta-analysis review | Q35639506 | ||
Polymorphism p53 codon-72 and invasive cervical cancer: a meta-analysis | Q35774090 | ||
Common variants in the ATM, BRCA1, BRCA2, CHEK2 and TP53 cancer susceptibility genes are unlikely to increase breast cancer risk | Q35794359 | ||
Association of TP53 codon 72 polymorphism and the outcome of adjuvant therapy in breast cancer patients | Q35906322 | ||
Estrogen receptor alpha polymorphisms and postmenopausal breast cancer risk | Q36412900 | ||
Polymorphisms in the p53 pathway. | Q36426763 | ||
Implication of BRCA2 -26G>A 5' untranslated region polymorphism in susceptibility to sporadic breast cancer and its modulation by p53 codon 72 Arg>Pro polymorphism | Q36458780 | ||
The R72P P53 mutation is associated with familial breast cancer in Jewish women | Q36616536 | ||
Obesity and prognosis of breast cancer | Q36622232 | ||
P53 codon 72 polymorphism and gastric cancer: a meta-analysis of the literature | Q36839254 | ||
Is the p53 codon 72 polymorphism a key biomarker for cervical cancer development? A meta-analysis review within European populations. | Q36958899 | ||
Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women | Q37090766 | ||
The possible involvement of virus in breast cancer | Q37325562 | ||
Association of p53 codon Arg72Pro and p73 G4C14-to-A4T14 at exon 2 genetic polymorphisms with the risk of Japanese breast cancer. | Q38347647 | ||
No evidence of correlation between p53 codon 72 polymorphism and risk of bladder or breast carcinoma in Tunisian patients | Q39199067 | ||
Role of p53 codon 72 arginine allele in cell survival in vitro and in the clinical outcome of patients with advanced breast cancer | Q39963569 | ||
Assessing publication bias in genetic association studies: evidence from a recent meta-analysis. | Q40464249 | ||
Codon 72 polymorphism of the TP53 gene | Q40522948 | ||
Retention of the p53 codon 72 arginine allele is associated with a reduction of disease-free and overall survival in arginine/proline heterozygous breast cancer patients | Q40622483 | ||
The codon 72 polymorphic variants of p53 have markedly different apoptotic potential | Q40672888 | ||
Expression of the mutated p53 tumor suppressor protein and its molecular and biochemical characterization in multidrug resistant MCF-7/Adr human breast cancer cells | Q41132525 | ||
Family history and the risk of breast cancer: a systematic review and meta-analysis | Q41495151 | ||
A meta-analysis of TP53 codon 72 polymorphism and lung cancer risk: evidence from 15,857 subjects | Q43552748 | ||
The proline form of p53 codon 72 polymorphism is associated with endometriosis | Q43846887 | ||
The TP53 codon 72 polymorphism may affect the function of TP53 mutations in breast carcinomas but not in colorectal carcinomas. | Q44258889 | ||
p53 codon 72 polymorphism (C/G) and the risk of human papillomavirus-associated carcinomas in China | Q44299674 | ||
Possible difference in frequencies of genetic polymorphisms of estrogen receptor alpha, estrogen metabolism and P53 genes between estrogen receptor-positive and -negative breast cancers | Q44325520 | ||
P53 codon 72 polymorphism in breast cancer | Q44396389 | ||
Polymorphism of the p53 codon 72 Arg/Pro and the risk of HPV type 16/18-associated cervical and oral cancer in India. | Q44631153 | ||
P53 codon 72 polymorphism and risk of gastric cancer in a Chinese population | Q44834112 | ||
Association of p53 genetic polymorphism (Arg72Pro) with estrogen receptor positive breast cancer risk in Japanese women | Q44926364 | ||
Study of p53 codon 72 polymorphism in patients with breast cancer | Q45223841 | ||
Fok1 polymorphism of vitamin D receptor gene contributes to breast cancer susceptibility: a meta-analysis | Q46162058 | ||
Analysis of p53 gene polymorphisms and protein over-expression in patients with breast cancer. | Q46219855 | ||
The association of p53 mutations and p53 codon 72, Her 2 codon 655 and MTHFR C677T polymorphisms with breast cancer in Northern Greece | Q46443444 | ||
Breast cancer patients with p53 Pro72 homozygous genotype have a poorer survival | Q46610600 | ||
Evidence for selective expression of the p53 codon 72 polymorphs: implications in cancer development | Q46711410 | ||
MDM2 SNP309 G allele increases risk but the T allele is associated with earlier onset age of sporadic breast cancers in the Chinese population | Q46748574 | ||
p53 Codon 72 polymorphism predicts the pathologic response to neoadjuvant chemotherapy in patients with breast cancer | Q46769388 | ||
Association of p53 polymorphisms and its haplotypes with susceptibility of breast cancer | Q46860143 | ||
Role of a p53 polymorphism in the development of human papillomavirus-associated cancer | Q48024470 | ||
Polymorphism of TP53 codon 72 showed no association with breast cancer in Iranian women. | Q51767667 | ||
Evidence for an association of TP53 codon 72 polymorphism with breast cancer risk. | Q51776297 | ||
Meta-analysis of genetic association studies. | Q52966223 | ||
Genetic variation in TP53 and risk of breast cancer in a population-based case control study. | Q53334287 | ||
Genetic polymorphisms in base-excision repair pathway genes and risk of breast cancer. | Q53349070 | ||
p53 haplotype determination in breast cancer. | Q53446391 | ||
p53 polymorphisms and haplotypes in breast cancer. | Q53454066 | ||
Polymorphisms of the TP53 codon 72 and WRN codon 1367 in individuals from Northern Brazil with gastric adenocarcinoma. | Q54626326 | ||
P53 mutations in colorectal cancer from northern Iran: Relationships with site of tumor origin, microsatellite instability and K-ras mutations | Q57157305 | ||
LOH rather than genotypes ofTP53codon 72 is associated with disease-free survival in primary breast cancer | Q58213042 | ||
p53 codon 72 polymorphism as a risk factor in the development of breast cancer | Q73080758 | ||
A p53 genetic polymorphism as a modulator of hepatocellular carcinoma risk in relation to chronic liver disease, familial tendency, and cigarette smoking in hepatitis B carriers | Q74529921 | ||
Intron 3 16 bp duplication polymorphism of p53 is associated with an increased risk for breast cancer by the age of 50 years | Q77858499 | ||
Prognostic significance of p53 codon 72 polymorphism in lung carcinomas | Q78128600 | ||
Polymorphism of XRCC1 (at codon 399) and susceptibility to breast cancer, a meta-analysis of the literatures | Q81280245 | ||
TP53 gene mutations of lung cancer patients in upper northern Thailand and environmental risk factors | Q81701810 | ||
Methylenetetrahydrofolate reductase gene and susceptibility to breast cancer: a meta-analysis | Q83185623 | ||
P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
P6216 | copyright status | copyrighted | Q50423863 |
P921 | main subject | breast carcinoma | Q18555947 |
P304 | page(s) | 115 | |
P577 | publication date | 2009-08-14 | |
P1433 | published in | Journal of Experimental & Clinical Cancer Research | Q13739415 |
P1476 | title | Polymorphisms of TP53 codon 72 with breast carcinoma risk: evidence from 12226 cases and 10782 controls | |
P478 | volume | 28 |
Q82288012 | A small number of subjects do not always indicate that they are minor variants data for inclusion in a pooled analysis |
Q33766324 | Assessment of changes in the BRCA2 and P53 genes in breast invasive ductal carcinoma in northeast Brazil. |
Q33597618 | Association between polymorphisms in TP53 and MDM2 genes and susceptibility to prostate cancer |
Q60934669 | Association of Single-Nucleotide Polymorphisms in Monoubiquitinated FANCD2-DNA Damage Repair Pathway Genes With Breast Cancer in the Chinese Population |
Q58002983 | Association of TP53 mutations with TP53 codon 72 polymorphism and outcome in triple-negative breast cancer |
Q41674458 | Association of Two Polymorphic Codons in P53 and ABCC1 Promoter with Prostate Cancer |
Q35661603 | Association of the TP53 codon 72 polymorphism and breast cancer risk: a meta-analysis |
Q28386766 | Combined effects of MDM2 SNP309 and TP53 R72P polymorphisms, and soy isoflavones on breast cancer risk among Chinese women in Singapore |
Q43541896 | Epistatic interaction of Arg72Pro TP53 and -710 C/T VEGFR1 polymorphisms in breast cancer: predisposition and survival |
Q42489213 | Estrogen receptor-alpha promoter methylation in sporadic basal-like breast cancer of Chinese women |
Q39137962 | Evaluation of polymorphic variants in apoptotic genes and their role in susceptibility and clinical progression to systemic lupus erythematosus |
Q58886632 | RAD51 135G>C and TP53 Arg72Pro polymorphisms and susceptibility to breast cancer in Serbian women |
Q50251932 | TP53 codon 72 polymorphism in pigmentary phenotypes |
Q37552336 | The Evaluation of p53 Polymorphism at Codon 72 and Association With Breast Cancer in Iran: A Systematic Review and Meta-analysis |
Q82249007 | Tp53 codon-72 polymorphisms identify different radiation sensitivities to g2-chromosome breakage in human lymphoblast cells |
Search more.